Repeated treatment with antidepressants enhances dopamine D1 receptor gene expression in the rat brain

European Journal of Pharmacology

Volumn 532, Issue 3, 2006, Pages 208-213

  Huzarska, Małgorzata ^a   Zieliński, Marek ^a   Herman, Zbigniew S ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Amitryptyline; Dopamine receptor; Mirtazapine; Nucleus accumbens; RT PCR (Reverse Transcriptase Polymerase Chain Reaction); Sertraline; Striatum

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MIRTAZAPINE; SERTRALINE;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; MALE; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; OPTICAL DENSITY; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; STATISTICAL SIGNIFICANCE;

AMITRIPTYLINE; ANIMALS; ANTIDEPRESSIVE AGENTS; CORPUS STRIATUM; GENE EXPRESSION REGULATION; MALE; MIANSERIN; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RNA, MESSENGER; SERTRALINE; TIME FACTORS;

EID: 33644542712     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.09.069     Document Type: Article

References (53)

1. G.B. Baker, and A.J. Greenshaw Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system Cell. Mol. Neurobiol. 9 1989 1 44
2. 3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of he cerebellum in the rat Prog. Neuro-psychopharmacol. Biol. Psychiatry 29 2005 718 726
3. J.N. Carlson, K.E. Visker, D.M. Nielsen, R.W. Keller Jr., and S.D. Glick Chronic antidepressant drug treatment reduces turning behavior and increases dopamine levels in the medial prefrontal cortex Brain Res. 707 1996 122 126
4. A. Carlsson, N. Waters, and M.L. Carlsson Neurotransmitter interactions in schizophrenia - therapeutic implications Biol. Psychiatry 15 1999 1388 1395
5. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction Anal. Biochem. 162 1987 156 159
6. O. Civelli, J.R. Bunzow, D.K. Grandy, Q-Y. Zhou, and H.H.M. van Tol Molecular biology of the dopamine receptors Eur. J. Pharmacol. 207 1991 277 286
7. R.N. Clark, C.R. Ashby Jr., S.L. Dewey, P.V. Ramachandran, and R.E. Strecker Effect of acute and chronic fluoxetine on extracellular dopamine levels in the caudate-putamen and nucleus accumbens of rat Synapse 23 1996 125 131
8. P.S. D'Aquila, M. Collu, G.L. Gess, and G. Serra The role of dopamine in the mechanism of action of antidepressant drugs Eur. J. Pharmacol. 405 2000 365 373
9. 2 dopamine receptors in the rat brain J. Neural Transm. 104 1997 515 524
10. M. Dziedzicka-Wasylewska, P. Willner, and M. Papp Changes in dopamine receptor mRNA expression following chronic mild stress and chronic antidepressant treatment Behav. Pharmacol. 8 1997 607 618
11. J.D. Flory, J.J. Mann, S.B. Manuck, and M.F. Muldoon Recovery from major depression is not associated with normalization of serotonergic function Biol. Psychiatry 43 1998 320 326
12. H. Freeman Early onset of action of amineptine Int. Clin. Psychopharm. 12 1997 29 33
13. 1 dopamine receptors in rats reproduces a model of escape deficit reverted by imipramine, fluoxetine and clomipramine Prog. Neuro-psychopharmacol. Biol. Psychiatry 19 1995 741 755
14. 1 dopamine receptors in mediating the antidepressant effect of imipramine Pharmacol. Biochem. Behav. 50 1995 147 151
15. S. Garattini Pharmacology of amineptine, an antidepressant agent acting on the dopaminergic system: a review Int. Clin. Psychopharm. 12 1997 15 19
16. 1 dopamine receptor supersensitivity in the dopamine-depleted striatum animal model of Parkinson's disease Neuroscientist 9 2003 455 462
17. 1 receptor in schizophrenia: insight for cognitive dysfunction Psychopharmocology 174 2004 3 16
18. C. Holmes, H. Smith, R. Ganderton, M. Arranz, D. Collier, J. Powell, and S. Lovestone Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation J. Neurol. Neurosurg. Psychiatry 71 2001 777 779
19. 1 receptor signaling in the nucleus accumbens Synapse 45 2002 159 170
20. P. Hunt, M. Kannengiesser, and J. Raynaud Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum J. Pharm. Pharmacol. 26 1974 370 371
21. J. Ichikawa, and H.Y. Meltzer Effect of antidepressants on striatal and accumbens extracellular dopamine levels Eur. J. Pharm. 281 1995 255 261
22. - SCH23390 binding sites in rat striatum and the limbic system E. J. Pharm. 139 1987 163 169
23. V. Klimek, G. Nowak, and A. Czyrak Central effects of repeated treatment with bupropion Pol. J. Pharmacol. Pharm. 37 1985 243 252
24. 3 receptor gene expression as a common effect of chronic antidepressant treatments Mol. Psychiatry 5 2000 378 388
25. M. Maes, and H.Y. Meltzer The serotonin hypothesis of major depression F.E. Bloom D.J. Kupfer Psychopharmacology: the Fourth Generation of Progress 1995 Raren Press Ltd. New York 933 944
26. 4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system New Biol. 4 1992 137 146
27. K. Mizoguchi, M. Yuzurihara, M. Nagata, A. Ishige, H. Sasaki, and T. Tabira Dopamine-receptor stimulation in the prefrontal cortex ameliorates stress-induced rotarod impairment Pharmacol. Biochem. Behav. 72 2002 723 728
28. National Center for Biotechnology Information, A 17753, 1991. Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides. Patent: WO 9115513-A 13 17-Oct-1991.
29. G.N. Ossowska, G. Nowak, B. Klenk-Majewska, Z. Danilczuk, and I. Żebrowska-Łupina Brain monoamine receptors in a chronic unpredictable stress model in rats J. Neural Transm. 108 2001 311 319
30. M. Piechaczyk, J.M. Blanchard, L. Marty, C. Dani, F. Panabieres, S. El Sabouty, P. Fort, and P. Jeanteur Post-transcriptional regulation of glyceraldehyde-3-phosphate dehydrogenase gene expression in rat tissues Nucleic Acids Res. 12 1984 6951 6963
31. W.Z. Potter, F. Grossman, and M.V. Rudoerfer Noradrenergic function in depressive disorders J.J. Mann D.J. Kupfer Biology of Depressive Disorders, Part A: Systems Perspective 1993 Plenum Press New York, NY 1 27
32. A. Randrup, I. Munkrad, and R. Fog Mania, depression and brain dopamine W.B. Essman L. Valzelli Current Developments in Psychopharmacology 1975 Spectrum New York 206 248
33. 2 dopamine receptor as revealed by the polymerase chain reaction FEBS Lett. 263 1990 18 22
34. J.J. Schildkraut The catecholamine hypothesis of affective disorders: a review of supporting evidence Am. J. Psychiatry 122 1965 509 522
35. J.K. Seamans, and C.R. Yang The principal features and mechanisms of dopamine modulation in the prefrontal cortex Prog. Neurobiol. 74 2004 1 58 (and erratum 74, 321)
36. 2 receptors in rat and human striatal tissues Synapse 47 2003 250 254
37. 1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants Brain Res. 527 1990 234 243
38. 3) as a target for neuroleptics Nature 347 1990 146 151
39. J.C. Stoof, and J.W. Kebabian Two dopamine receptors; biochemistry, physiology, pharmacology Life Sci. 35 1984 2281 2296
40. F. Sulser, J. Vetulani, and P.L. Mobley Mode of action of antidepressant drugs Biochem. Pharmacol. 27 1978 257 271
41. 1-like dopamine receptors Psychopharmacology 144 1999 95 110
42. P. Svenningsson, J. Arts, L. Gunne, and P.E. Andren Acute and repeated treatment with L-DOPA increase c-jun expression in the 6-hydroxydopamine- lesioned forebrain of rats and common marmosets Brain Res. 955 2002 8 15
43. A. Svensson, M.L. Carlsson, and A. Carlsson Glutamatergic neurons projecting to the nucleus accumbens can affect motor functions in opposite directions depending on the dopaminergic tone Prog. Neuro-psychopharmacol. Biol. Psychiatry 18 1994 1203 1218
44. 1A receptor Proc. Natl. Acad. Sci. U. S. A. 88 1991 7491 7495
45. J.M. Vaugeois, A.T. Corera, A. Deslandes, and J. Costentin Although chemically related to amineptine, the antidepressant tianeptine is not a dopamine uptake inhibitor Pharm. Biochem. Behav. 63 1999 285 290
46. P.C. Waldemeier Effects of antidepressant drugs on dopamine uptake and metabolism J. Pharm. Pharmacol. 34 1982 391 394
47. P.C. Waldemeier Effects of chronic treatment on pre- and post-synaptic dopaminergic mechanisms. A short review of the literature and some complementary experiments Pol. J. Pharmacol. Pharm. 36 1984 201 216
48. B.H.C. Westerink Can antipsychotic drugs be classified by their effects on a particular group of dopamine neurons in the brain? Eur. J. Pharmacol. 455 2002 1 18
49. P. Willner Dopaminergic mechanisms in depression and mania F.E. Bloom D.J. Kupfer Psychopharmacology 1995 Raven Press Ltd. New York 921 931
50. P. Willner The mesolimbic dopamine system as a target for rapid antidepressant action Int. Clin. Psychopharmacol. 3 1997 S7 S14
51. P. Willner, R. Muscat, and M. Papp Chronic mild stress-induced anhedonia: realistic animal model of depression Neurosci. Biobehav. Rev. 19 1992 525 534
52. 1 receptor is a critical mediator for cocaine-induced gene expression J. Neurochem. 82 2002 1453 1464
53. 1 receptor gene J. Neurochem. 59 1992 1875 1883